Neutrophil-Lymphocyte Ratio as a Potential Biomarker for Schizophrenia Severity: A Cross-Sectional Study
Rashmi Meena, Ragini Meena, Jiwan S Meena

TL;DR
This study suggests that the neutrophil-lymphocyte ratio (NLR) could be a useful and inexpensive biomarker for measuring the severity of schizophrenia.
Contribution
The study demonstrates that NLR is strongly correlated with schizophrenia severity and is elevated in untreated patients.
Findings
Untreated schizophrenia patients had significantly higher NLR values compared to treated patients.
NLR was strongly correlated with symptom severity as measured by the BPRS.
Abstract
Background: Schizophrenia is a chronic psychiatric disorder with a complex etiology, and inflammation has been increasingly implicated in its pathophysiology. The neutrophil-lymphocyte ratio (NLR), a simple hematological marker, may serve as an adjunctive biomarker for disease severity. Objective: To evaluate the association between NLR and schizophrenia severity, and to compare inflammatory status between treated and untreated patients. Methods: A hospital-based cross-sectional study was conducted among 100 patients with International Classification of Diseases, Tenth Revision (ICD-10)-diagnosed schizophrenia. Of 143 patients screened, 43 were excluded. Symptom severity was assessed using the Brief Psychiatric Rating Scale (BPRS). Complete blood counts were analyzed to calculate NLR. Statistical analysis included Welch’s t-test, chi-square test, and Pearson’s correlation (α = 0.05).…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsTryptophan and brain disorders · Schizophrenia research and treatment · Neuroinflammation and Neurodegeneration Mechanisms
